NCIt related terms : Monoclonal antibodies against SARS-CoV-2: bebtelovimab;
NCIt definition : A neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a
patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against
the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
that can potentially be used for immunization against COVID-19. Upon administration,
bebtelovimab specifically targets and binds to the receptor-binding domain (RBD) of
SARS-CoV-2 S protein, thereby blocking viral attachment and entry into human cells
and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease
and accelerate recovery, and may potentially provide temporary protection against
infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2,
plays an essential role in the infection pathway of the SARS-CoV-2 virus.;
UNII : 8YL4SYR6CU;
CAS number : 2578319-11-4;
Molecule name : LY 3853113; LY-CoV1404; LY CoV1404; LY-3853113;